At a glance
ClinicalIndex Comparison RecordN/AActive· 1,093 enrolled
Drug / intervention
EaseVRx +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Decentralized, Randomized, Controlled Trial to Study Health Outcomes of EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain
In Brief
A clinical study evaluating EaseVRx and Sham VR for Chronic Low-back Pain and 2 related conditions. Active but no longer recruiting, targeting 1,093 participants across 1 site.
Detailed Summary
The aim of this randomized controlled trial (RCT) is to assess outcomes for virtual reality therapy (including pain intensity, pain interference, anxiety, depression, physical function, sleep, behavioral skills development, health outcomes and satisfaction) along with healthcare utilization and costs in participants with Chronic Low Back Pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low-back Pain, Anxiety, Depression
CountriesUnited States
Collaborators--
Timeline
N/AActiveOverdue
20222023202420252026
Enrollment StartJan 2022
First PostedMar 2022
Primary CompletionOct 2022
Study CompletionJun 2026
TodayJul 2026
First PostedMar 2, 2022
Enrollment StartJan 31, 2022
Primary CompletionOct 13, 2022
Study CompletionJun 1, 2026
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.3 years ago
Interventions
EaseVRxdevice
VR software with interactive content
Sham VRdevice
VR with neutral non-interactive content